AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines-Reference-Cited by-同舟云学术

AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines

Published:2024-07 Issue:7 Volume:63 Page:663-665
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

Cortese Samuele^ORCID,Coghill David^ORCID,Mattingly Gregory W.,Rohde Luis Augusto^ORCID,Thom Robyn P.^ORCID,Wilens Timothy E.^ORCID,Wong Ian C.K.^ORCID,Faraone Stephen V.^ORCID

Publisher

Elsevier BV

Reference9 articles.

1. What is the WHO essential medicines list?;Purgato;Epidemiol Psychiatr Sci,2012

2. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Storebø;Cochrane Database Syst Rev,2023

3. Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater;Banaschewski;Evid Based Ment Health,2016

4. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis;Cortese;Lancet Psychiatry,2018

5. Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases;Chang;Biol Psychiatry,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the Editor-in-Chief's Desk: Advances in Patient-Centered Treatment for Attention-Deficit/Hyperactivity Disorder;Journal of Child and Adolescent Psychopharmacology;2024-04-01